Poland· PL-100468640

Pirfenidone Aurovitas

A pirfenidone product containing pirfenidonum, registered in Poland by Aurovitas Pharma Polska Sp. z o.o.. The same ATC class is registered in 17 of our 19 countries.

ATC L04AX05

Checked against URPL (Poland) on September 27, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about pirfenidonumAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Pirfenidone is registered in 17 of 19 countries.

Countries holding a registration under ATC L04AX05 (pirfenidone), each read from that country’s own register.

This record: Poland, from URPL (Poland)
9 of them publish a price we can compare per daily dose

Search pirfenidone products by name

Pirfenidone · ATC L04AX05

17 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Japan
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of pirfenidone costs, country by country.

Normalised to the WHO defined daily dose (2.4 g), the median price runs from $27.36 in France to $63.67 in Switzerland — a ×2.3 gap.

2 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Pirfenidone · price per daily dose (2.4 g)

USD · FX 28 Sept 2026

CH Switzerland$63.67
FR France$27.36

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)

Active substance: Pirfenidonum
Manufacturer: Aurovitas Pharma Polska Sp. z o.o.
Country: Poland (PL)
ATC code: L04AX05
ATC class: Pirfenidone
Defined daily dose: 2.4 g, O
Reimbursed: Not published by this register
Source register: URPL (Poland)
Last checked: September 27, 2026

Packs & prices · 13

gtin
05909991523794
gtin
05909991523695
gtin
05909991523701
gtin
05909991523718
gtin
05909991523725
gtin
05909991523732
gtin
05909991523749
gtin
05909991523756
gtin
05909991523763
gtin
05909991523770
gtin
05909991523787
gtin
05909991523800
gtin
05907394784552

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

132 interactions on record for pirfenidone.

Graded by severity as the source publishes them — 20 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check pirfenidone against other medicines How interaction checks work

Pirfenidone · interactions on record

132 records

20 severe
110 moderate
2 minor

Most severe, free to view

GivosiranA16AX16severe
AmiodaroneC01BD01severe
MipomersenC10AX11severe
LomitapideC10AX12severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Pirfenidone in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All pirfenidone products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

Austria · Pirfenidon Accord, Pirfenidon Actavis
Belgium · Perfenidon Eg, Pirfenidon Cipla
Bulgaria · Fredalix
Cyprus · Pirfenidone Accord, Pirfenidone Msn
Czechia · Fredalix, Pirfenidon Zentiva
Germany · Equitor, Pirfenair
Denmark · Fredalix, Pirfenair
Estonia · Pirfenidone Accord, Pirfenidone Msn
Spain · Pirfenidona Accord, Pirfenidona Aurovitas
Finland · Pirfenidon Cipla, Pirfenidone Accord
France · Pirfenidon Eg Labo - Laboratoireseurogenerics, Pirfenidone Accord
United Kingdom (Northern Ireland) · Pirfenidon Msn Laboratories Europe, Pirfenidone
Greece · Orepir, Pirfenidone Accord
Croatia · Pirfenidon Accord, Pirfenidon Sandoz
Hungary · Pirfenidon Zentiva
Ireland · Pirfenidone Accord, Pirfenidone Axunio
Iceland · Esbriet, Pirfenidon Medical Valley
Italy · Blamonehel, Pirfenidone Accord
Liechtenstein · Esbriet, Pirfenidone Viatris
Lithuania · Pirfenidone Accord, Pirfenidone Msn
Luxembourg · Pirfenidon Eg
Latvia · Pirfenidone Accord, Pirfenidone Msn
Malta · Pirfenidone Clonmel, Pirfenidone Msn
Netherlands · Pirfenidon Accord, Pirfenidon Amarox
Norway · Esbriet, Pirfenidon Cipla
Portugal · Pirfenidona Accord, Pirfenidona Generis
Romania · Pirfenidon Msn
Sweden · Pirfenidon Cipla, Pirfenidon Medical Valley
Slovenia · Pirfenidon Accord, Pirfenidon Teva
Slovakia · Pirfenidón Accord, Pirfenidone Msn

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/fd5bcd0c-e57b-4520-8779-d9b5c9890957
GET /v1/drugs/fd5bcd0c-e57b-4520-8779-d9b5c9890957?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki",
  "source": "urpl",
  "strength": "801 mg",
  "packaging": "05909991523695 ¦ Rpz ¦ 151673\n252 tabl.\n05909991523701 ¦ Rpz ¦ 151674\n28 tabl.\n05909991523718 ¦ Rpz ¦ 151675\n84 tabl. w blistrze\n05909991523725 ¦ Rpz ¦ 151676\n49 tabl.\n05909991523732 ¦ Rpz ¦ 151677\n168 tabl.\n05909991523749 ¦ Rpz ¦ 151678\n21 tabl.\n05909991523756 ¦ Rpz ¦ 151679\n63 tabl.\n05909991523763 ¦ Rpz ¦ 151680\n56 tabl.\n05909991523770 ¦ Rpz ¦ 151681\n7 tabl.\n05909991523787 ¦ Rpz ¦ 151682\n14 tabl.\n05909991523794 ¦ Rpz ¦ 151683\n35 tabl.\n05909991523800 ¦ Rpz ¦ 151684\n42 tabl.\n05907394784552 ¦ Rpz ¦ 167214\n84 tabl. w blistrze perforowanym",
  "substance": "Pirfenidonum 801 mg",
  "common_name": "Pirfenidonum",
  "pl_product_id": "100468640",
  "pozwolenie_nr": "28049",
  "auth_procedure": "DCP",
  "authorisation_validity": "2028-10-19"
}

API reference MCP server Plans

See everything about pirfenidone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console